Esperion Therapeutics is a pharmaceutical company. It specializes in developing and commercializing oral, low‑density lipoprotein cholesterol (LDL-C) therapies for patients with hypercholesterolemia.
|HQ||Ann Arbor, MI, US||Map|
Gross profit (Q2, 2021)
Gross profit margin (Q2, 2021), %
Net income (Q2, 2021)
EBIT (Q2, 2021)
Market capitalization (16-Sept-2021)
Closing stock price (16-Sept-2021)
|USD||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q3, 2020||Q1, 2021||Q2, 2021|
Depreciation and Amortization
Esperion Therapeutics has 1.3k Twitter Followers. The number of followers has increased 1.3% month over month and increased 4.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Esperion Therapeutics founded?
Esperion Therapeutics was founded in 2008.
Who are Esperion Therapeutics key executives?
Esperion Therapeutics's key executives are Richard Bartram, Ashley Hall and Ken Fiorelli.
How many employees does Esperion Therapeutics have?
Esperion Therapeutics has 193 employees.
What is Esperion Therapeutics revenue?
Latest Esperion Therapeutics annual revenue is $227.5 m.
What is Esperion Therapeutics revenue per employee?
Latest Esperion Therapeutics revenue per employee is $1.2 m.
Who are Esperion Therapeutics competitors?
Competitors of Esperion Therapeutics include CSPC Pharmaceutical Group, Macleods Pharmaceuticals and Sandoz.
Where is Esperion Therapeutics headquarters?
Esperion Therapeutics headquarters is located at 3891 Ranchero Dr, Ann Arbor.
Where are Esperion Therapeutics offices?
Esperion Therapeutics has an office in Ann Arbor.
How many offices does Esperion Therapeutics have?
Esperion Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies